UBS downgrades adidas to sell as footwear slowdown threatens 2027 growth
Source: Investing.com

UBS downgraded Adidas to sell from neutral and cut its 12-month price target to €156 from €160, implying about 10% downside from Monday’s €172.85 close. UBS forecasts 2027 FX-adjusted sales growth of 4%, versus 7% consensus, gross margin of 51.3% versus 52.3%, and EBIT margin of 9.1% versus 10%; it expects 2027–28 operating profit to be more than 10% below market expectations. The bank cites fading footwear momentum, weaker underlying industry growth, higher input costs and the reversal of 2026 tariff-refund benefits.
Analysis
The key risk is not simply slower category growth; it is a franchise-replacement and earnings-quality problem. If Terrace demand fades before newer lifestyle products gain traction, adidas may need more promotion or wholesale support to sustain volume, pressuring both realized pricing and channel mix. That could turn a sales-growth shortfall into a disproportionate operating-profit miss. World Cup demand also risks pulling purchases forward, making the post-event comparison unusually difficult. Performance products offer a partial offset, but decelerating running momentum weakens the assumption that one category can absorb a lifestyle reset.
For the next 1–3 months, watch estimate revisions, sell-through and inventory/discounting signals: the downgrade matters most if analysts begin converging toward lower growth and margin assumptions, rather than remaining an isolated bearish view. Over 6–18 months, oil-linked inputs and the roll-through of currency hedges can compound mix pressure; a stronger dollar is a later risk, not necessarily an immediate earnings shock. Lower oil costs, successful new-franchise launches, or resilient performance demand would invalidate the downside case. The contrarian risk is that expectations already begin to reset after a prominent downgrade, while a single broker’s forecast is not proof of deterioration. Avoid treating the entire sportswear group as exposed to adidas’s specific product-cycle issue.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
Key Decisions for Investors
- Prefer a staged, relative-value short in XETR:ADS versus a diversified consumer/sportswear basket, rather than an outright sector short. Initiate only if subsequent estimate revisions or trading updates confirm weaker sell-through or margin guidance; the thesis is franchise transition plus operating leverage, not merely the downgrade.
- Do not chase an immediate gap lower. Use the next earnings update and channel checks as entry catalysts; reduce or cover if lifestyle sell-through stabilizes without heavier discounting and management maintains credible margin guidance.
- Track quarterly lifestyle growth, running momentum, gross-margin guidance, inventory and promotional intensity, plus oil and EUR/USD trends. A clear reacceleration in new franchises or margin delivery near market expectations would falsify the bearish setup.
- Keep position sizing mindful of a sharp rebound risk: successful product launches, stronger-than-expected performance demand, lower input costs, or tariff-related offsets could support earnings before the longer-term FX headwind arrives.
More News
- 5 things to watch on Election Day as Democrats push for control of Congress
- Marvell, Lumentum tout historic $115B deal to create ‘category leader' in AI connectivity
- New Apple CEO John Ternus chalks up some early wins, but the honeymoon is over
- The AI boom is facing another supply crunch. This time it’s the amount of capital available to feed Silicon Valley’s endless need for cash
- Bayer Raises Profit Outlook Helped by Strong Demand for Drugs
- Apple and Palantir shares slide in premarket trading following post-bell earnings